Long Term Evaluation of Scapular-inserted Contraceptive Implants

NCT07201402 ↗

Phase 2 Recruiting 62 enrolled Yale University Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab

NaSingle-groupOpen-labelPrevention

Summary

This study aims to evaluate long-term outcomes when the etonogestrel contraceptive implant is inserted at an alternative site located over the scapular. The study will evaluate the pharmacokinetics (i.e., drug levels) and side effect profiles of participants who have an etonogestrel contraceptive implant inserted at this alternative scapular site over the course of at least two years.

Timeline

Start: 2026-05-08
Primary completion: 2027-10
Completion: 2027-10

Publications

Background Clure C, Sheeder J, Lazorwitz A. Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant. Contraception. 2024 Jul;135:110442. doi: 10.1016/j.contraception.2024.110442. Epub 2024 Mar 27.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Etonogestrel	Unknown	—	Subcutaneous

Indications

No indication recorded.